Due to a production error, Table 1 in the CME supplement, Re-examining the Optimal Use of Neuromodulators and the Changing Landscape: A Consensus Panel Update (J Drugs Dermatol. 2020; 19:4 Supp 1) contained the incorrect composition in the first column. The correct Table is below and available at https://jddonline.com/articles/dermatology/S1545961620S0035X/1
